Shree Hari Chemicals Export Ltd
Incorporated in 1987, Shree Hari Chemicals Export Ltd is a manufacturer of H-Acid[1]
- Market Cap ₹ 64.7 Cr.
- Current Price ₹ 102
- High / Low ₹ 154 / 87.6
- Stock P/E 15.3
- Book Value ₹ 80.2
- Dividend Yield 0.00 %
- ROCE 11.4 %
- ROE 11.0 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Promoter holding has increased by 5.01% over last quarter.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.9% over last 3 years.
- Earnings include an other income of Rs.3.06 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | 101 | 115 | 55 | 51 | 57 | 56 | 76 | 103 | 138 | 141 | 184 | |
| 81 | 100 | 116 | 64 | 53 | 58 | 54 | 76 | 126 | 135 | 131 | 178 | |
| Operating Profit | 50 | 1 | -1 | -10 | -3 | -1 | 2 | 0 | -23 | 4 | 11 | 7 |
| OPM % | 38% | 1% | -1% | -18% | -5% | -1% | 4% | 0% | -23% | 3% | 8% | 4% |
| 2 | 3 | 2 | 1 | 1 | 1 | 1 | 3 | 1 | 4 | 1 | 3 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 2 | 2 |
| Depreciation | 3 | 3 | 3 | 4 | 3 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 49 | 1 | -2 | -12 | -4 | -2 | 1 | 1 | -26 | 3 | 7 | 5 |
| Tax % | 34% | -19% | 10% | -27% | -15% | -17% | 32% | 37% | -25% | 29% | 26% | 20% |
| 32 | 1 | -2 | -9 | -4 | -2 | 1 | 1 | -20 | 2 | 5 | 4 | |
| EPS in Rs | 72.13 | 2.52 | -4.25 | -19.70 | -8.03 | -3.60 | 1.89 | 1.53 | -44.53 | 5.15 | 10.38 | 7.62 |
| Dividend Payout % | 3% | 40% | -24% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 27% |
| 3 Years: | 22% |
| TTM: | 31% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 38% |
| 3 Years: | 30% |
| TTM: | -17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 6% |
| 3 Years: | 31% |
| 1 Year: | -25% |
| Return on Equity | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | -5% |
| 3 Years: | 14% |
| Last Year: | 11% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 6 |
| Reserves | 47 | 48 | 46 | 37 | 33 | 32 | 32 | 33 | 14 | 16 | 27 | 39 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 22 | 30 | 27 | 26 | 29 | |
| 42 | 45 | 32 | 15 | 8 | 21 | 23 | 33 | 42 | 24 | 28 | 29 | |
| Total Liabilities | 93 | 98 | 82 | 56 | 46 | 57 | 60 | 93 | 90 | 72 | 87 | 102 |
| 15 | 13 | 17 | 15 | 12 | 10 | 8 | 15 | 18 | 18 | 17 | 21 | |
| CWIP | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 4 | 0 | 1 | 4 | 8 |
| Investments | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 12 |
| 78 | 82 | 64 | 41 | 34 | 47 | 50 | 74 | 70 | 53 | 65 | 62 | |
| Total Assets | 93 | 98 | 82 | 56 | 46 | 57 | 60 | 93 | 90 | 72 | 87 | 102 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27 | 6 | 5 | 4 | -5 | 0 | -1 | 5 | -4 | 10 | -1 | 11 | |
| -5 | -1 | -4 | 1 | 1 | 1 | -0 | -11 | -2 | -1 | -5 | -19 | |
| -1 | -1 | -1 | -1 | -0 | 0 | 0 | 5 | 6 | -5 | 4 | 8 | |
| Net Cash Flow | 21 | 3 | 1 | 4 | -4 | 1 | -1 | -1 | 0 | 3 | -3 | -0 |
| Free Cash Flow | 20 | 3 | -0 | 4 | -5 | 0 | -1 | -6 | -6 | 8 | -7 | 1 |
| CFO/OP | 85% | 695% | -491% | -41% | 196% | -14% | -49% | 2,278% | 16% | 266% | -14% | 167% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 37 | 48 | 73 | 58 | 36 | 134 | 157 | 81 | 98 | 58 | 73 | 48 |
| Inventory Days | 148 | 71 | 60 | 79 | 81 | 88 | 89 | 358 | 97 | 37 | 56 | 37 |
| Days Payable | 105 | 108 | 111 | 97 | 53 | 177 | 198 | 257 | 156 | 78 | 100 | 72 |
| Cash Conversion Cycle | 80 | 12 | 22 | 39 | 63 | 44 | 48 | 182 | 39 | 16 | 29 | 13 |
| Working Capital Days | 29 | 24 | 38 | 48 | 49 | 68 | 83 | 64 | -47 | -37 | -18 | -21 |
| ROCE % | 135% | 2% | -3% | -26% | -11% | -5% | 3% | 5% | -46% | 12% | 18% | 11% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Export of Goods (FOB Basis) Rs. Lakhs |
|
||||||||||
| Number of Employees Count |
|||||||||||
| Installed Production Capacity MT per Annum |
|||||||||||
| Volume of H-Acid Sold MT |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
21 May - Secretarial compliance report for FY2026 shows nil deviations and full SEBI LODR compliance.
-
Statement Under Regulation 32(1) For The Quarter Ended 31.03.2026
15 May - Filed NIL deviation statement for ₹14.75 crore preferential issue proceeds for quarter ended March 31, 2026.
-
Results-31-03-2026
15 May - Board approved audited standalone and consolidated results for Q4/FY26; auditors issued unmodified opinion.
-
Board Meeting Outcome for Audited Financial Statements & Results For The Quarter And Year Ended 31.03.2026
15 May - Board approved FY2026 audited standalone and consolidated results on May 15, 2026; auditors issued unmodified opinion.
-
Board Meeting Intimation for Approval Of Audited Financial Statements (Standalone & Consolidated) For The Year Ended March 31, 2026, Audited Financial Results (Standalone & Consolidated) For The Quarter And Year Ended March 31, 2026 And Recommendation Of Dividend, If Any.
8 May - Board meets May 15, 2026 to approve FY26 audited results and consider dividend; trading window reopens May 18.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Profile:
a) H-Acid:[1]
These are used as intermediates for dyestuffs
b) Acid Dyes:[2]
These are water soluble anionic dyes that are applied to fibers
c) Direct Dyes:[3]
Company manufactures Class A, Class B and Class C types of dyes
d) Intermediates Dyes:[4]
Koch Acid, R Salt, Peri Acid, Tobias Acid, G Salt, Sulfa Tobias Acid, etc.
e) Reactive Dyes:[5]
These are used for dyeing cellulose, protein and polyamide fibers